Is Adial Pharmaceuticals, Inc. (ADIL) a Buy, Sell, or Hold?
Adial Pharmaceuticals, Inc.
NASDAQ:ADIL
$2.65 USD
-$0.18 (-6.36%)
- Volume
- 65.83K
- Average Volume
- 479.39K
- Market Capitalization
- $2.54M
- P/E Ratio
- -0.27
- Dividend Yield
- 0.00%
- Price Target
- $7.00
- Year High
- $19.00
- Year Low
- $1.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.18
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
30
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
0
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ -
ADIL Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ADIL Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Coastlands Capital LP | 10 percent owner | 2026-07-10 | P-Purchase | 2.7 | 2026-07-13 |
| Coastlands Capital LP | 10 percent owner | 2026-07-09 | P-Purchase | 2.79 | 2026-07-13 |
| Coastlands Capital LP | 10 percent owner | 2026-06-29 | P-Purchase | 2.6 | 2026-07-01 |
| Coastlands Capital LP | 10 percent owner | 2026-06-24 | 0 | 2026-06-29 | |
| Coastlands Capital LP | 10 percent owner | 2026-06-24 | 0.001 | 2026-06-29 | |
| Davidson Matt | director, officer: Chief Development Officer | 2026-06-12 | A-Award | 0 | 2026-06-16 |
| Davidson Matt | director, officer: Chief Development Officer | 2026-06-12 | A-Award | 2.89 | 2026-06-16 |
| Davidson Matt | director, officer: Chief Development Officer | 2026-06-11 | A-Award | 0 | 2026-06-16 |
| Davidson Matt | director, officer: Chief Development Officer | 2026-06-11 | A-Award | 0 | 2026-06-16 |
| Davidson Matt | director, officer: Chief Development Officer | 2026-06-11 | A-Award | 0 | 2026-06-16 |
| Davidson Matt | director, officer: Chief Development Officer | 2026-06-11 | A-Award | 0 | 2026-06-16 |
| Davidson Matt | director, officer: Chief Development Officer | 2026-06-11 | 0 | 2026-06-16 | |
| Young Wendy B. | director | 2026-06-12 | P-Purchase | 0.001 | 2026-06-16 |
| Young Wendy B. | director: | 2026-06-11 | 0 | 2026-06-16 | |
| Goodman Tony | director, officer: Chief Operating Officer | 2026-04-07 | A-Award | 0 | 2026-04-09 |
| Anderson J. Kermit | director | 2026-04-07 | A-Award | 1.64 | 2026-04-09 |
| Schuyler Kevin | director | 2026-04-07 | A-Award | 0 | 2026-04-09 |
| Shah Vinay | officer: Chief Financial Officer | 2026-04-07 | A-Award | 0 | 2026-04-09 |
| Gilliland Robertson H. | director | 2026-04-07 | A-Award | 0 | 2026-04-09 |
| Claiborne Cary J | director, officer: Chief Executive Officer | 2026-04-07 | A-Award | 0 | 2026-04-09 |
| Gilliland Robertson H. | director | 2025-05-29 | A-Award | 0.688 | 2025-06-02 |
| Newman James W. Jr. | director | 2025-05-29 | A-Award | 0.688 | 2025-06-02 |
| Shah Vinay | officer: Chief Financial Officer | 2025-05-29 | A-Award | 0.688 | 2025-06-02 |
| Schuyler Kevin | director | 2025-05-29 | A-Award | 0.688 | 2025-06-02 |
| Claiborne Cary J | director, officer: Chief Executive Officer | 2025-05-29 | A-Award | 0.688 | 2025-06-02 |
| Goodman Tony | director, officer: Chief Operating Officer | 2025-05-29 | A-Award | 0.688 | 2025-06-02 |
| Anderson J. Kermit | director | 2025-05-29 | A-Award | 0.688 | 2025-06-02 |
| Claiborne Cary J | director, officer: Chief Executive Officer | 2024-12-05 | A-Award | 1.15 | 2024-12-05 |
| Shah Vinay | officer: Chief Financial Officer | 2024-11-16 | A-Award | 1.06 | 2024-11-18 |
| Shah Vinay | officer | 2024-11-16 | 0 | 2024-11-18 | |
| Gilliland Robertson H. | director | 2024-03-25 | A-Award | 1.35 | 2024-03-27 |
| Newman James W. Jr. | director | 2024-03-25 | A-Award | 1.35 | 2024-03-27 |
| Truluck Joseph | officer: Chief Financial Officer | 2024-03-25 | A-Award | 1.35 | 2024-03-27 |
| Claiborne Cary J | director, officer: Chief Executive Officer | 2024-03-25 | A-Award | 1.35 | 2024-03-27 |
| Anderson J. Kermit | director | 2024-03-25 | A-Award | 1.35 | 2024-03-27 |
| Schuyler Kevin | director | 2024-03-25 | A-Award | 1.35 | 2024-03-27 |
| Goodman Tony | director, officer: Chief Operating Officer | 2024-03-25 | A-Award | 1.35 | 2024-03-27 |
| Schuyler Kevin | director | 2023-09-29 | P-Purchase | 2.74 | 2023-10-03 |
| Johnson Bankole A. | director | 2023-05-23 | A-Award | 0.3025 | 2023-06-02 |
| Truluck Joseph | officer: Chief Financial Officer | 2023-05-23 | A-Award | 0 | 2023-05-25 |
| Truluck Joseph | officer: Chief Financial Officer | 2023-05-23 | A-Award | 0.3025 | 2023-05-25 |
| Stilley William B. III | director | 2023-05-23 | A-Award | 0 | 2023-05-25 |
| Stilley William B. III | director | 2023-05-23 | A-Award | 0.3025 | 2023-05-25 |
| Schuyler Kevin | director | 2023-05-23 | A-Award | 0.3025 | 2023-05-25 |
| Newman James W. Jr. | director | 2023-05-23 | A-Award | 0.3025 | 2023-05-25 |
| Goodman Tony | director | 2023-05-23 | A-Award | 0.3025 | 2023-05-25 |
| Gilliland Robertson H. | director | 2023-05-23 | A-Award | 0.3025 | 2023-05-25 |
| Claiborne Cary J | director, officer: Chief Executive Officer | 2023-05-23 | A-Award | 0 | 2023-05-25 |
| Claiborne Cary J | director, officer: Chief Executive Officer | 2023-05-23 | A-Award | 0.3025 | 2023-05-25 |
| Anderson J. Kermit | director | 2023-05-23 | A-Award | 0.3025 | 2023-05-25 |
| Stilley William B. III | director | 2022-12-30 | D-Return | 0 | 2023-01-03 |
| Claiborne Cary J | director, officer: Chief Executive Officer | 2022-09-20 | A-Award | 0.4202 | 2022-09-20 |
| Claiborne Cary J | director, officer: Chief Executive Officer | 2022-09-19 | A-Award | 0.4294 | 2022-09-20 |
| Stilley William B. III | director | 2022-08-22 | A-Award | 0.555 | 2022-08-23 |
| Stilley William B. III | director: | 2022-08-22 | A-Award | 0 | 2022-08-23 |
| Claiborne Cary J | officer: Chief Executive Officer | 2022-08-18 | A-Award | 0 | 2022-08-22 |
| Goodman Tony | director: | 2022-06-27 | A-Award | 0 | 2022-06-28 |
| Johnson Bankole A. | officer: Chief Medical Officer | 2022-02-23 | A-Award | 2 | 2022-02-25 |
| Goodman Tony | director | 2022-02-23 | A-Award | 2 | 2022-02-25 |
| Truluck Joseph | officer: Chief Financial Officer | 2022-02-23 | A-Award | 2 | 2022-02-25 |
| Stilley William B. III | director, officer: Chief Executive Officer | 2022-02-23 | A-Award | 0 | 2022-02-25 |
| Schuyler Kevin | director | 2022-02-23 | A-Award | 2 | 2022-02-25 |
| Newman James W. Jr. | director | 2022-02-23 | A-Award | 2 | 2022-02-25 |
| Gilliland Robertson H. | director | 2022-02-23 | A-Award | 2 | 2022-02-25 |
| Claiborne Cary J | officer: Chief Operating Officer | 2022-02-23 | A-Award | 2 | 2022-02-25 |
| Anderson J. Kermit | director | 2022-02-23 | A-Award | 2 | 2022-02-25 |
| Newman James W. Jr. | director | 2021-12-30 | P-Purchase | 2.72 | 2022-01-03 |
| Newman James W. Jr. | director | 2021-12-30 | P-Purchase | 2.71 | 2022-01-03 |
| Newman James W. Jr. | director | 2021-12-30 | P-Purchase | 2.66 | 2022-01-03 |
| Schuyler Kevin | director, 10 percent owner: | 2021-12-23 | G-Gift | 0 | 2021-12-23 |
| Schuyler Kevin | director, 10 percent owner: | 2021-12-23 | G-Gift | 6.25 | 2021-12-23 |
| Claiborne Cary J | director, officer: Chief Operating Officer | 2021-12-07 | A-Award | 2.77 | 2021-12-08 |
| Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 2021-11-30 | P-Purchase | 2.7527 | 2021-12-01 |
| Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 2021-11-29 | P-Purchase | 2.5892 | 2021-12-01 |
| Newman James W. Jr. | director | 2021-11-26 | P-Purchase | 2.85 | 2021-11-30 |
| Claiborne Cary J | director | 2021-11-02 | A-Award | 3.15 | 2021-11-03 |
| Claiborne Cary J | director: | 2021-11-02 | 0 | 2021-11-03 | |
| Johnson Bankole A. | officer: Chief Medical Officer | 2021-10-04 | S-Sale | 200000 | 2021-10-06 |
| Johnson Bankole A. | officer: Chief Medical Officer | 2021-10-04 | J-Other | 0 | 2021-10-06 |
| Johnson Bankole A. | officer: Chief Medical Officer | 2021-04-06 | S-Sale | 2.5 | 2021-04-08 |
| Truluck Joseph | officer: Chief Financial Officer | 2021-02-08 | A-Award | 3.11 | 2021-02-10 |
| Stilley William B. III | director, officer: Chief Executive Officer | 2021-02-08 | A-Award | 3.11 | 2021-02-10 |
| Schuyler Kevin | director | 2021-02-08 | A-Award | 3.11 | 2021-02-10 |
| Newman James W. Jr. | director | 2021-02-08 | A-Award | 3.11 | 2021-02-10 |
| Goodman Tony | director | 2021-02-08 | A-Award | 3.11 | 2021-02-10 |
| Gilliland Robertson H. | director | 2021-02-08 | A-Award | 3.11 | 2021-02-10 |
| Anderson J. Kermit | director | 2021-02-08 | A-Award | 3.11 | 2021-02-10 |
| Stilley William B. III | director, 10 percent owner, officer: Chief Executive Officer | 2021-01-26 | A-Award | 0 | 2021-01-28 |
| Newman James W. Jr. | director | 2021-01-26 | A-Award | 0 | 2021-01-28 |
| Newman James W. Jr. | director | 2021-01-26 | A-Award | 0 | 2021-01-28 |
| Schuyler Kevin | director, 10 percent owner: | 2018-11-12 | J-Other | 5 | 2020-11-25 |
| Schuyler Kevin | director, 10 percent owner: | 2018-11-12 | J-Other | 6.25 | 2020-11-25 |
| Schuyler Kevin | director, 10 percent owner: | 2018-11-12 | J-Other | 5 | 2020-11-25 |
| Schuyler Kevin | director, 10 percent owner: | 2018-11-12 | J-Other | 6.25 | 2020-11-25 |
| Schuyler Kevin | director, 10 percent owner: | 2018-11-12 | J-Other | 5 | 2020-11-25 |
| Schuyler Kevin | director | 2018-07-31 | P-Purchase | 5 | 2020-11-25 |
| Schuyler Kevin | director | 2018-07-31 | J-Other | 0 | 2020-11-25 |
| Schuyler Kevin | director | 2018-07-31 | J-Other | 6.25 | 2020-11-25 |
| Schuyler Kevin | director | 2018-07-31 | J-Other | 5 | 2020-11-25 |
| Schuyler Kevin | director | 2018-07-31 | J-Other | 0 | 2020-11-25 |